Status:
RECRUITING
DCS Versus DES for One-month DAPT in Patients With ACS: ONE-PASS Trial
Lead Sponsor:
Yonsei University
Conditions:
Acute Coronary Syndrome
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
To test whether the polymer-free drug-coated stent (DCS) BioFreedom is noninferior to the biodegradable polymer drug-eluting stent (DES) Ultimaster in terms of 1-year patient-oriented composite endpoi...
Detailed Description
This trial is an open-label, randomized, multi-center study. Patients with ACS requiring percutaneous coronary intervention will be randomized with a 1:1 ratio either of DCS group or DES group. After ...
Eligibility Criteria
Inclusion
- Age ≥19 years
- All subjects who are acceptable candidates for treatment with a drug-coated stent or drug-eluting stent because of acute coronary syndrome
- Provision of informed consent
Exclusion
- Current or potential pregnancy
- Need of oral anticoagulation therapy
- Inability to follow the patient over the period of 1 year after enrollment, as assessed by the investigator
Key Trial Info
Start Date :
August 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 14 2030
Estimated Enrollment :
3520 Patients enrolled
Trial Details
Trial ID
NCT05305482
Start Date
August 10 2022
End Date
February 14 2030
Last Update
May 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yonsei Cardiovascular Hospital, Yonsei University College of Medicine
Seoul, South Korea